F. DeWolfe Miller
Epidemiologist
Curriculum Vita – Resume
Tenured, Full Professor
Professor of Epidemiology
Professor of Microbiology
Emeritus Professor of
Epidemiology
January 2, 2020
EDUCATION & CREDENTIALS
University of Michigan
Epidemiology Ph.D.
1978
University of Michigan Environmental-Health
M.P.H.
1974
University of Tennessee Immunology Virology M.S.
1969
Tennessee Technological University Biology B.S. 1965
Fellow in
the American College of Epidemiology F.A.C.E.
1985
Senior
Fulbright
Scholar Egypt
1994
Senior Fulbright Scholar
Egypt 2008
ADDRESS
Department
of Tropical Medicine and Medical Microbiology and Pharmacology
John A. Burns School of Medicine
University of Hawaii at Manoa
651 Ilalo Street, Biosciences Building 320,
Honolulu, Hawaii 9681
Office (808) 692-1605 Mobile (808) 386-4869
FAX: (808) 692-1979
Email: dewolfe@hawaii.edu and dewolfemiller@gmail.com
Home
Page
NEW
PUBLICATION ON screening of 67,000 Egyptians for HCV and HBV.
Gamal Soliman, Mahmoud S. Elzalabany, Tarek Hassanein and F. DeWolfe Miller. Mass screening for hepatitis B and C in Southern Upper Egypt, BMC Public Health (2019) 19:1326 https://doi.org/10.1186/s12889-019-7640-1
On Line at https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-7640-1
BMC
Public Health 19,
Article number: 1326 (2019) Cite this article
It is well documented that Egypt has the highest
prevalence of hepatitis C virus (HCV) infection in the world. The recent
development of highly effective direct acting antiviral drugs (DAAs), has
opened the possibility of treating and curing HCV infection in the Egyptian
population on a large scale.
A screening demonstration project was implemented in
southern Egypt in and around the city of Luxor. Free screening and if
indicated, treatment, was offered to those 16 years or older for anti-HCV
antibodies (anti-HCV) and hepatitis B surface antigen (HBsAg) using third
generation enzyme immunoassays (Enzygnost® Anti-HCV and HbsAg). Statistical
methods included estimation of odds ratios (OR) and 95% confidence intervals
(95% CI).
There was a large turnout of 67,042 persons who were
screened in a 12-month period starting in June 2016. Thirty-one thousand nine
hundred sixty-four males (47.7%) and 35,074 females (52.3%) were screened with
a mean age of 43.6 ± 14.3 years. Nine thousand seven hundred one patients
(14.5%) were positive for anti-HCV and 2950 (4.4%) for HBsAg. Prevalence of
anti-HCV was significantly higher in males than females (19.67% vs.9.73%
OR = 2.27; CI 2.2 to 2.4; p < 0.001)
and the same for HBsAg (6.2% vs. 2.8% OR = 2.3; CI 2.2 to 2.5; p < 0.001). The prevalence of anti-HCV was
significantly associated with age (p < 0.001),
ranging from between 1 and 4% in individuals below the age of 40 years, then
increased steadily to 42% at age 60 followed by a precipitous decline in age
specific prevalence.
The results showed unanticipated patterns in the Luxor
area of anti-HCV and HBsAg by age and gender in contrast to previous reports on
this unique HCV epidemic in Egypt. Moreover, the level and rate of turnout,
cost, and other logistical issues, provided essential information for effective
planning, design, and evaluation methods for larger national mass screening and
treatment programs.
1. Miller
FD. The Effects of Chemical Immunosuppression on SV40 Tumor Transplantation
Immunity In Vivo [Master]. Knoxville,
Tennesse: University of Tennesse, Knoxville; 1968 (Dec).
2. Miller FD. Immunological Aspects of
Striated Muscle Transplantation. . Third Annual Medical Congress. Pahlavi
Medical School, Shiraz, Iran; 1972.
3. Miller FD. Schistosomiasis in rural
Egypt : a report of U. S.-Egyptian River Nile and Lake Nasser research project.
In: Environmental Research Laboratory (Athens Ga.), editor. EPA: Environmental
health effects research series. Athens, Ga.:
Environmental Research Laboratory, Office of Research and Development, U. S. Environmental Protection Agency : Springfield, Va. : available through National Technical Information Service; 1978. p. xviii, 206 p.
4. Miller FD. Studies on Schistosomiasis
in Rural Egypt Following the Construction of the Aswan High Dam [Dissertation].
Ann Abor, Michigan: University of Michigan; 1978.
5. Miller FD, Hussein M, Mancy KH, and ,
Hilbert MS. Aspects of Environmental Health Impacts of the Aswan High Dam on
Rural Populations in Egypt. Progress in
Water Technology 1978; 11((1/2)):
173-80.
6. Miller FD. Environmental health impacts
of the Aswan High Dam in Egypt. . International
Symposium on Engineering Science and Medicine in the Prevention of Tropical
Water-Related Disease. London School of Tropical Medicine and Hygiene and
the Institution of Civil Engineers, London, England.; 1979.
7. Miller FD, Mancy KH, King C, Hilbert
MS, Hussein M. Schistosome Patterns in Egypt. Lancet 1979; 6: 749.
8. Miller FD. Human intestinal parasitic
infections and environmental health factors in rural Egyptian communities : a
report of the U. S.-Egyptian River Nile and Lake Nasser Research Project. In:
Environmental Research Laboratory (Athens Ga.), Project. US-ERNaLNR, editors.
EPA. Athens, Ga.: Environmental Research Laboratory, Office of Research and
Development, U. S. Environmental Agency; 1980. p. x, 151 p.
9. Miller FD. Human intestinal parasitic
infections and environmental health factors in rural Egyptian communities : a
report of the U.S.-Egyptian River Nile and Lake Nassar research project. In:
Environmental Research Laboratory (Athens Ga.), Project. US-ERNaLNR, editors.
EPA. Athens, Ga. : Springfield, Va.: Environmental Research Laboratory, Office
of Research and Development, U.S. Environmental Protection Agency ; Available
to the public through the National Technical Information Service; 1980. p. x,
151 pages.
10. Miller FD. A brief Assessment of Water
Supply and Waste Disposal Systems in Developing Countries. Approtech 1980; 3.
11. Miller F, Hussein M, Mancy KH, Hilbert
MS, Monto AS, Barakat RM. An epidemiological study of Schistosoma haematobium
and S. mansoni infection in thirty-five rural Egyptian villages. Tropical and geographical medicine 1981;
33(4): 355-65.
12. King CL, Miller FD, Hussein M, Barkat R,
Monto AS. Prevalence and intensity of Schistosoma haematobium infection in six
villages of upper Egypt. The American
journal of tropical medicine and hygiene 1982; 31(2): 320-7.
13. Miller FD, El-Hakim SM, Bruce JI. An
epidemiological investigation of health risks related to solid waste salvage
and recycling in an Egyptian community. Tropical
and geographical medicine 1982; 34(3):
241-9.
14. Monto AS, Miller FD, Maassab HF.
Evaluation of an attenuated, cold-recombinant influenza B virus vaccine. J Infect Dis 1982; 145(1): 57-64.
15. Miller FD. Problems of water storage in
the rural village home: the Egyptian zir. The
Journal of tropical medicine and hygiene 1984; 87(2): 53-9.
16. Miller FD, Brilliant LB, Copeland R.
Polybrominated biphenyls in lactating Michigan women: Persistence in the
population. Bulletin of Environmental
Contamination and Toxicology 1984; 32(1):
125-33.
17. Miller FD, Hicks SP, D'Amato CJ, Landis
JR. A descriptive study of neuritic plaques and neurofibrillary tangles in an
autopsy population. Am J Epidemiol
1984; 120(3): 331-41.
18. Miller FD, Monto AS, DeLong DC, Exelby A,
Bryan ER, Srivastava S. Controlled trial of enviroxime against natural
rhinovirus infections in a community. Antimicrob
Agents Chemother 1985; 27(1):
102-6.
19. Miller FD. Boiling drinking water
programs: A critical look. . Waterlines
1986; 5((1)): 2-5.
20. Miller FD. Water consumption and demand
measurements for single family households: A pilot approach. . Journal of
Environmental Health 1987; 50:
13-7. .
21. Miller FD, Reed DM, MacLean CJ. A
prospective study of mortality and morbidity among carpenters in the Honolulu
Heart Program Cohort. J Occup Med
1988; 30(11): 879-82.
22. Miller FD, Michael JM. Environmental
health education in Micronesia. Asia Pac
J Public Health 1989; 3(1):
51-60.
23. Reed D, LaCroix, AZ, Karasek, RA, Miller,
D., & MacLean, CA. Occupational strain and the incidence of coronary heart
disease. American Journal of Epidemiology
1989; 129((3)): 495-502.
24. Curb JD, Reed DM, Miller FD, Yano K.
Health status and life style in elderly Japanese men with a long life
expectancy. J Gerontol 1990; 45(5): S206-11.
25. Kloos H, Higashi G, Schinski VD, Mansour
NS, Murrell KD, Miller FD. Water contact and Schistosoma haematobium infection:
a case study from an upper Egyptian village. Int J Epidemiol 1990; 19(3):
749-58.
26. Miller FD. The Impact of the United
Nations International Decade for Drinking Water Supply and Sanitation on
Schistosomiasis. A Special Report to the United Nations General Assembly: . In:
Schistosomiasis, editor. IDWSSD ed. United Nations Secretary General at the
World Health Organization, Geneva: World Health Organization, Geneva; 1990.
27. Kungskulniti N, Pulket C, Miller FD,
Smith KR. Solid waste scavenger community: an investigation in Bangkok,
Thailand. Asia Pac J Public Health
1991; 5(1): 54-65.
28. Miller FD. Bacterial contamination of
water resources on Moen, Truk Islands, Federated States of Micronesia. In:
Geological S, University of Hawaii at M, editors. Technical memorandum ;no 83.
Honolulu, Hawaii: Water Resources Research Center, University of Hawaii at
Manoa; 1991. p. xiii, 45 p.
29. Kamel MA, Ghaffar YA, Wasef MA, Wright M,
Clark LC, Miller FD. High HCV prevalence in Egyptian blood donors. Lancet 1992; 340(8816): 427.
30. Barakat R, Farghaly A, el-Sawy MF, et al.
An epidemiological assessment of Ambrosia
maritima on the transmission of schistosomiasis in the Egyptian Nile Delta.
Trop Med Parasitol 1993; 44(3): 181-6.
31. Kamel M, Kuhns MC, Miller FD, et al. High
hepatitis C seroprevalence and serum viremia with normal alanine
aminotransferase levels among blood donors and rural villagers in Egypt. . Hepatology 1993; 18(4(Part 2)).
32. Kamel M, Miller F, Troonen H, Ghaffar YA.
Independent association of HBsAg and HCV with hepatocellular carcinoma (HCC) in
an area of high endemicity: Egypt. Hepatology
1993; 18(4): 2.
33. Miller FD, Reed DM, Banta J. Sugarcane
workers: morbidity and mortality. Hawaii
Med J 1993; 52(11): 300-3, 6.
34. Miller FD, Reed DM, MacLean CJ. Mortality
and morbidity among blue and white collar workers in the Honolulu Heart Program
cohort. Int J Epidemiol 1993; 22(5): 834-7.
35. Kamel M, El Manialawi M, Miller FD. Recombinant
hepatitis B vaccine immunogenicity in presence of hepatitis C virus
seropositivity. Lancet 1994; 343(8896): 552.
36. Kamel MA, Miller FD, el Masry AG, et al.
The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection
in Egypt. Ann Trop Med Parasitol
1994; 88(5): 501-9.
37. Barakat R, el Masry AG, Farghaly A, et
al. Impact of population-based selective chemotherapy on prevalence and
intensity of Schistosoma mansoni infections in the Nile Delta: Kafr El Sheikh. Tropical and geographical medicine 1995;
47(6): 266-70.
38. Barakat R, Farghaly A, el Masry AG,
elSayed MK, Husein MH, Miller FD. Schistosoma mansoni in the Nile Delta, Egypt.
A large scale epidemiological study in Kafr El Sheikh Governorate. Tropical and geographical medicine 1995;
47(6): 259-65.
39. Barakat R, Farghaly A, Morshidy HN, et
al. Patterns of infection, incidence and reinfection with Schistosoma mansoni
in Nile Delta Governorate: Kafr El Sheikh. Tropical
and geographical medicine 1995; 47(6):
270-7.
40. Kamel MA, Troonen H, Kapprell HP,
el-Ayady A, Miller FD. Seroepidemiology of hepatitis E virus in the Egyptian
Nile Delta. J Med Virol 1995; 47(4): 399-403.
41. El Sayed MK, Barakat R, Farghaly A, et
al. The impact of passive chemotherapy on Schistosoma mansoni prevalence and
intensity of infection in the Egyptian Nile Delta. The American journal of tropical medicine and hygiene 1997; 57(3): 266-71.
42. Miller FD. High seroprevalence of
hepatitis A, B, C, and E virus in an Egyptian village in the Nile Delta. The American journal of tropical medicine and
hygiene 1997; 57(3): 251.
43. Miller FD. Schistosomiasis and Hepatitis
C Virus in Egypt. . Health Issues in the Middle East. University
of Michigan. Ann Arbor, Michigan.: University of Michigan. Ann Arbor, Michigan.;
1997.
44. Barakat R, Farghaly A, El Morshidy HN,
Hassan M, Miller FD. Impact of National Schistosomiasis Control Program in Kafr
el Sheikh Governorate, Nile Delta, Egypt: An independent evaluation. Journal of the Egyptian Public Health
Association 1998; 73(5,6):
737-53.
45. Rashida Barakat, Azza Farghaly, Hala N.
El Morshidy, Mohammed Hassan, Miller FD. Impact of National Schistosomiasis
Control Program in Kafr el Sheikh Governorate, Nile Delta, Egypt: An
independent evaluation. The Journal of
the Egyptian Public Health Association 1998; LXXIII: ((5,6) ): 737-53.
46. Talaat M, Miller FD. A mass chemotherapy
trial of praziquantel on Schistosoma haematobium endemicity in Upper Egypt. The American journal of tropical medicine
and hygiene 1998; 59(4): 546-50.
47. Nerurkar VR, Woodward CL, Nguyen HT, et
al. Lack of association between acquisition of TT virus and risk behavior for
HIV and HCV infection in Vietnam. Int J
Infect Dis 1999; 3(4): 181-5.
48. Talaat M, El-Ayyat A, Sayed HA, Miller
FD. Emergence of Schistosoma mansoni infection in upper Egypt: the Giza
governorate. The American journal of
tropical medicine and hygiene 1999; 60(5):
822-6.
49. El-Khoby T, Hussein MH, Galal N, Miller
FD. Epidemiology 1, 2, 3: origins, objectives, organization, and
implementation. The American journal of
tropical medicine and hygiene 2000; 62(2
Suppl): 2-7.
50. Hussein MH, El-Sayed MK, Talaat M,
El-Badawy A, Miller FD. Epidemiology 1, 2, 3: study and sample design. The American journal of tropical medicine
and hygiene 2000; 62(2 Suppl):
8-13.
51. Katz AR, Miller FD. The role of
epidemiology in graduate medical education. Hawaii
Med J 2002; 61(5): 102-3.
52. Lasher LE, Elm JL, Hoang Q, et al. A case
control investigation of hepatitis C risk factors in Hawaii. Hawaii Med J 2005; 64(11): 296-300, 2-4.
53. Li F, Park SY, Ayers TL, et al.
Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002. Emerg Infect Dis 2005; 11(8): 1205-10.
54. Shimizu SM, Chow DC, Katz AR,
Richmond-Crum S, Miller FD. Ethnic differences in HIV disease progression: a
comparison of Asian/Pacific Islanders and Whites living in Hawaii. Ethn Dis 2006; 16(1): 262-7.
55. Li F, Arnsberger P, Miller FD. Profile of
methicillin-resistant Staphylococcus aureus among nursing home residents in
Hawai'i. Hawaii Med J 2010; 69(5): 126-9.
56. Li F, Miller FD, Effler PV. Epidemiology
of methicillin-resistant Staphylococcus aureus among incarcerated population in
Hawai'i, 2000-2005. Hawaii Med J
2010; 69(4): 99-102.
57. Miller FD. Population incidence estimates
for hepatitis C virus infection in Egypt. International
Journal of Infectious Diseases 2010; 14(PIIS1201971210004959.pdf):
e379.
58. Miller FD, Abu-Raddad LJ. Evidence of
intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A 2010; 107(33): 14757-62.
59. Ruth Bastable G, UK, Sylvie Briand
c-ootI, Respiratory , Diseases HaPfuatWH, et al. The Silent Pandemic. Tackling
Hepatitis C with Policy Innovation. The Economist. 2012.
60. Chemaitelly H, Abu-Raddad LJ, Miller FD.
An apparent lack of epidemiologic association between hepatitis C virus
knowledge and the prevalence of hepatitis C infection in a national survey in
Egypt. PLoS One 2013; 8(7): e69803.
61. Miller FD, Abu-Raddad LJ. Quantifying
current hepatitis C virus incidence in Egypt. J Viral Hepat 2013; 20(9):
666-7.
62. Mohamoud YA, Mumtaz GR, Riome S, Miller
D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic
review and data synthesis. BMC Infect Dis
2013; 13: 288.
63. Cuadros DF, Branscum AJ, Miller FD,
Abu-Raddad LJ. Spatial epidemiology of hepatitis C virus infection in Egypt:
analyses and implications. Hepatology
2014; 60(4): 1150-9.
64. Miller FD. Epidemiology and Prevention of
HCV in Eygpt. BioVisionAlexandria 2014
Conference Bibliotheca Alexandrina,
Alexandria, Egypt
Invited Presentation
Grand Hall of the Bibliotheca Alexandrina 2014.
65. Mohamoud YA, Miller FD, Abu-Raddad LJ.
Potential for human immunodeficiency virus parenteral transmission in the
Middle East and North Africa: an analysis using hepatitis C virus as a proxy
biomarker. World J Gastroenterol
2014; 20(36): 12734-52.
66. Perumalswami PV, Miller FD, Orabee H, et
al. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant
community. Liver international : official
journal of the International Association for the Study of the Liver 2014; 34(2): 253-8.
67. Benova L, Awad SF, Miller FD, Abu-Raddad
LJ. Estimation of hepatitis C virus infections resulting from vertical
transmission in Egypt. Hepatology
2015; 61(3): 834-42.
68. Cuadros DF, Branscum AJ, Miller FD, Awad
SF, Abu-Raddad LJ. Are Geographical "Cold Spots" of Male Circumcision
Driving Differential HIV Dynamics in Tanzania? Front Public Health 2015; 3:
218.
69. Cuadros DF, Miller FD, Nagelkerke N,
Abu-Raddad LJ. Association between HCV infection and diabetes type 2 in Egypt:
is it time to split up? Ann Epidemiol
2015; 25(12): 918-23.
70. Hassanin FS, Schaalan MF, Kamal KM,
Miller FD. An Initial Investigation of Do Not Resuscitate Acceptance in Egypt. American Journal of Hospice and Palliative
Medicine 2015.
71. Miller FD, Elzalabany MS, Hassani S,
Cuadros DF. Epidemiology of hepatitis C virus exposure in Egypt: Opportunities
for prevention and evaluation. World J
Hepatol 2015; 7(28): 2849-58.
72. Chuang E, Lim E, Milne C, et al. Human
Papillomavirus at Multiple Sites Associated with Anal Squamous Intraepithelial
Lesions in HIV-Seropositive Individuals. Ann
Clin Cytol Pathol 2016; 2(4).
73. Hassanin FS, Schaalan MF, Kamal KM,
Miller FD. An Initial Investigation of Do Not Resuscitate Acceptance in Egypt. Am J Hosp Palliat Care 2016; 33(9): 823-8.
74. Miller FD. Hepatitis C virus in Arabian
Gulf countries: Implications and priorities. Int J Infect Dis 2016; 46:
115.
75. Mohsen DA, Hosny S, Morshedy N, Miller
FD, Elzalabany MS. Prevalence of Hepatitis C Virus Infection in Egyptian
Patients with Rheumatoid Arthritis ACR
2017; (Abstract).
76. Soliman G, Negm MS, Elzalabany M, et al.
Is treatment of hepatitis C with controlled generic direct acting antiviral
drugs effective? An Egyptian experience. Journal
of Hepatology 2018; 68: S276.
77. Soliman G, Negm MS, Elzalabany MS, et al.
High efficacy and safety of sofosbuvir plus daclatasvir for treatment of
hepatitis C virus genotype 4: a real life Egyptian experience. Submitted 2018.
78. Miller FD. Adapting Epidemologic Methods
to Investigate Iatrogenic Transmission and Evaluate Interventions in Egypt:
Understanding Exposure Epidemiology.
Alex-Health 2019. Alexandria, Egypt; 2019.
79. Soliman G, Elzalabany MS, Hassanein T,
Miller FD. Mass screening for hepatitis B and C in Southern Upper Egypt. BMC Public Health 2019; 19(1): 1326.
80. Cuadros DF, Miller FD. Barriers
Associated with Effective Use of Insecticide Treated Nets and Geographical
Identification of Vulnerable Children at Risk of Malaria in sub-Saharan Africa.
Malaria Journal 2020.
81. Hernandez A, Correa-Agudelo E, Kim H, et
al. On the impact of early non-pharmaceutical interventions as containment
strategies against the COVID-19 pandemic. Journal
of Infection 2020; YJINF-D-20-02111.
Past
Acting
Research
overview: Dr. Miller is recognized internationally for his contributions
to the epidemiology and control of schistosomiasis,
especially in
Dr. Miller was
the team leader and principal architect for the design of the $45 million Schistosomiasis Research
Project, and principal architect of its epidemiologic field studies, the
largest ever completed on schistosomiasis in
The prevention of Hepatitis C virus transmission in
Dr.
Miller is co‑discover of the largest epidemic of hepatitis C virus in the world today which is also located in
An article
appeared in the Daily Star Egypt regarding a key note address given at the
American University Cairo by Dr. Miller on HCV.
The link is given below.
http://www.dailystaregypt.com/article.aspx?ArticleID=6979
and www.hcvegypt.com.
Dr. Miller was a Senior Fulbright Scholar in
AAAS Science
Member Spotlight: Science website hosts a “spotlight” on selected members. I was
featured as a "spotlight" member. This is the link |
Dr. Miller obtained
a $1 million grant from the National Geographic Society for the Egyptian Mummy
Project and obtained a state of the art portable CT scanning machine for the
Egyptian Supreme Council of Antiquities, Dr. Zahi Hawass. This machine is currently located directly
behind the
He was CoPI
with Dr. R. Yanagihara on a dengue fever epidemiological proposal to PDVI for
$2 million. Although the proposal was awarded, delays in processing the award
by the University resulted in losing this investigation. A great deal of effort
had been made to win this award including two site visits to
BIBLIOGRAPHY Peer Reviewed Publications SEE Selected Publications above
Yousra
A Mohamoud, Ghina R Mumtaz, Suzanne Riome, DeWolfe
Miller and Laith J Abu-Raddad .The epidemiology of hepatitis C virus in
Egypt: a systematic review and data synthesis. BMC Infectious Diseases, 13:288 (24 Jun 2013)
http://www.biomedcentral.com/1471-2334/13/288
Total accesses to this article since
publication: > 20,000
Other HCV publications
Discovery of HCV in Egypt – the
World’s largest HCV epidemic.
Kamel, M.A., Ghaffar, Y.A.,
Wasef, M.A., Wright, M., Clark, L. C., Miller,
F. D.
1992. High HCV Prevalence in Egyptian Blood Donors. Lancet
340:427
Kamel
MA, Miller FD et al. 1994. The epidemiology of S. mansoni,
hepatitis B, and hepatitis C infection in
________________
Miller, F.
Rashida
Barakat, Azza Farghaly, Hala N. Morshidy, Medhat K. ElSayed, A.G. Masry, M.H.
Husein, F.
Miller,
F.D., Reed, D., Banta, J. 1993. An Epidemiological Investigation of
Sugar Cane
Reed,
D., LaCroix, A., Karasek, R.A., Miller,
F.D., and MacLean,C. 1989. Occupational strain and the incidence of
coronary heart disease. American
Journal of Epidemiology 129:495.*
UNIQUE ORGINIAL
LANDMARK STUDY ON Alzheimer’s DISEASE
Miller,
F.D., Hussein, M., Mancy, K.H., and Hilbert, M.S. 1978. Aspects of Environmental Health Impacts of
the
SPECIAL
REPORT - United
Nations General Assembly
Invited Presentation at the BioVisionAlexandria 2014
Conference
Epidemiology and Prevention of HCV in Eygpt: April 2014
Li F, Ayers TL, Park SY, Miller FD, MacFadden R, Effler PV, et al. Abstract
'Epidemiology of Methicillin-Resistant Staphylococcus aureus in Hawai'i:
Results from the State of Hawaii Antimicrobial Resistance Project (SHARP)". Poster presentation (No. 476)
at the 42nd Annual Meeting of Infectious Disease Society of American (IDSA),
Moyiyami Susan, Li F, Miller FD, MacFadden R, Effler PV, et al. Abstract "Comparing NCCLS Guidelines to Other
Methods for Removing Duplicates Isolates in Assessing Antimicrobial
Susceptibility Patterns,
Maddock, J.E., Nigg, C.R.,
Pressler V., Jackson S., Wood, B. & Miller,
F.D. (2004). Using tobacco settlement funds to rebuild a school of
public health. Presented at the STEP UP to Tobacco Control Meeting,
F.
Miller FD, El-Sayed MK, Farghaly A ,
El_Badway A , Soliman NK, Husein MH, Barakat R. 1995. The impact of passive
chemotherapy on Schistosoma mansoni prevalence and intensity of infection
in the Egyptian Nile
Kamel,
M; Troonen, H; El-Ayady, A; Miller, FD. 1995. Seroepidemiology of
hepatitis E virus (HEV) in the Egyptian Nile
El-Sayed,
M.K.; Barakat, R.; Farghaly, A.; El-Badawy, A.; Soliman, N. and Miller, F.D.
1993. The relationship between chemotherapy of schistosomiasis and prevalence
and intensity of infection: A community survey in
Kamel, M.A.; Barakat, R.; Husein, M.H.; and Miller, F.D. 1993. Interdisciplinary
resources required for epidemiological research in endemic infectious diseases.
Presented at the SRP International Conference On Schistosomiasis,
El-Sayed,
MK; Barakat, R.; Farghaly, A.; El-Badawy, A.; Soliman, N. and Miller, F.D. Relationship between passive
chemotherapy of schistosomiasis and prevalence and intensity of infection: A
community survey in
El-Sayed,
M.K.; Barakat, R.; Farghaly, A.; El-Badawy, A.; Soliman, N. and Miller, F.D. 1992. Passive chemotherapy
and the prevalence and intensity of infection of schistososmiasis. Presented at
the XIIIth International Congress For Tropical Medicine and Malaria, Jomitien,
Barakat, R.; El-Sayed, M.K.; Farghaly, A.; Soliman,
N.; Husein, M.H. and Miller, F.D. 1992.
Miller F DeWolfe
1990. Steering Committee for Cooperative Action for the International
Drinking Water Supply and Sanitation Decade. Report on ID WSSD impact on
schistosomiasis.
Kungskulniti, N., Pulket, C., Smith, K., Miller, F.D. 1990. Indoor
NO2 Levels in Low-Income Apartments in
Miller,
F.D. 1989. Water supply improvements reduce schistosomiasis prevalence
and incidence. WATER '89: An International Conference on WATER DECADE
AND BEYOND.
Miller,
F.D. 1988. Schistosomiasis control and the decade: Ecological
approaches to evaluation. Symposium on the Water and Sanitation
Miller,
F.D. 1988. Occupational Active
and Cardiovascular Disease Risk among Asian Americans: The
Miller,
F.D. and Convard, N. 1987. Water quality and the storage of water in
the village home. Proceedings of the
International Symposium on Water and Sanitation in
Miller,
F.D. and Convard, N. 1987. The
role of water supply and sanitation on Schistosomiasis: a look at the evidence.
Proceedings of the International Symposium on Water and Sanitation in
Convard,
N. and Miller, F.D. 1987. An experimental evaluation of
effectiveness of the continuous pot chlorinator for the disinfection of
drinking water. Proceedings of the International Symposium on Water and
Sanitation in
Miller,
F.D. 1986. Environmental health education in
Miller,
F.D. 1985. Neuropathological end_points for epidemiological studies on
dementia. U.S.-Japan Conference on Aging.
Miller,
F.D. 1979. Environmental health impacts of the Aswan High Dam in
Miller,
F.D., Hussein, M., Hilbert, M.S. and Mancy, K.H. 1978. Impacts of the
BOOKS
OR MONOGRAPHS
Miller,
F.
Miller,
F.D. 1987. Risk Characterization: Human Health, in Assessment of
Risks for the Management of Hazardous Chemical Systems in
Miller, F.D., and Hussein, M. 1980. A survey of Intestinal Parasites and Environmental Health Factors in
Rural Egyptian Communities. EPA
monograph 600/180024, pp. 151.
Miller,
F.D., Hussein, M., Hilbert, M.S., and Mancy, K.H. 1978. Schistosomiasis
in Rural
TECHNICAL
AND CONSULTING REPORTS
Miller, F.
Miller, F.D. 1995. Final Technical Report: An investigation of
acute asthma and exposure to sugarcane smoke:
A joint UH-DOH study of health and environment on
Miller, F.D., Moravcik, P.S., Siren,
N., William, S. 1991. Bacterial contamination of water resources on Moen,
Miller, F. D.,
Moravcik, P.S., Siren, N., and
Miller, F. D.,
Moravcik, P.S., Siren, N. and William, S. 1989. A further investigation into
potential contamination of water resources on Moen,
Miller, F. D. 1988.
Review of the final report on water quality and public health engineering for
JESS II project in
Miller, F. D.,
Editor and team leader. 1987. Schistosomiasis Research Project in
Miller, F. D.,
Fontaine, J., and Lovelace, N.L. 1986.
Water Supply, Sanitation and Health for
Miller, F. D. 1982.
Health implications of the development of the
Miller, F. D. 1981.
Analysis of environmental data from rural Egyptian villages.
Higashi,
G.I., Miller, F. D.,